Imago Biosciences

$22.14 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Imago Biosciences

Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing small molecule product candidates that target lysine-specific demethylase 1, an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago BioSciences serves medical sector in the United States.

Stock Analysis

last close $22.37
1-mo return -16%
3-mo return -14.8%
avg daily vol. 102.49T
52-week high 35.68
52-week low 14.99
market cap. $788M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 71.9%

Subscribe now for daily local and international financial news